A Study of Genetic Markers in Patients with Suspected Cardiac Channelopathies


About this study

This study is being done to identify underlying genetic defects in individuals from families who are at-risk of a possible cardiac channelopathy (abnormal electrical signals in the heart).

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Suspected channelopathy,
  • relative of established channelopathy,
  • case of SUD or SIDS

Exclusion Criteria:

  • Those patients who don't otherwise meet the specified inclusion criteria

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Michael Ackerman, M.D., Ph.D.

Open for enrollment

Contact information:

Carla Haglund-Turnquist

(507) 284-8900


More information


Publications are currently not available

Mayo Clinic Footer